Article
Impact of NUDT15 polymorphisms on thiopurines-induced myelotoxicity and thiopurines tolerance dose.
Oncotarget - 21 Feb 2017
Yin Dandan, Xia Xuyang, Zhang Junlong, Zhang Shouyue, Liao Fei, Zhang Ge, Zhang Yan, Hou Qianqian, Yang Xue, Wang Hong, Ma Zhigui, Wang Heyao, Zhu Yiping, Zhang Wei, Wang Yuelan, Liu Bo, Wang Lanlan, Xu Heng, Shu Yang
Abstract excerpt
Thiopurines are widely used as anticancer and immunosuppressive agents. However, life-threatening myelotoxicity has been noticed and largely explained by genetic variations, including NUDT15 polymorphisms (e.g., rs116855232). In this study, we conduct a meta-analysis to investigate the impact of rs116855232 on thiopurines-induced myelotoxicity susceptibility (1752 patients from 7 independent cohorts), as well as...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
